Swiss Pulse
InnovationRead the full story
ETH Zurich Develops Light-Controlled Cancer Treatment
Researchers at ETH Zurich have created a light-activated molecular switch to target lung cancer cells.
Researchers from ETH Zurich have developed a molecular switch that can be controlled by light. This technology reactivates lung cancer cells from a dormant state, making them more susceptible to treatment. The advancement could enhance the effectiveness of cancer therapies by allowing for targeted attacks on previously protected cells.
Share